How do i deal with the axilla in patients with a positive sentinel lymph node?

Current Treatment Options in Oncology

Volumn 12, Issue 4, 2011, Pages 389-402

  Falkson, Conrad B ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER STAGING; DISEASE FREE SURVIVAL; IMAGE GUIDED RADIOTHERAPY; INTENSITY MODULATED RADIATION THERAPY; INVASIVE CARCINOMA; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MASTECTOMY; MICROMETASTASIS; OVERALL SURVIVAL; PARTIAL MASTECTOMY; RECURRENCE FREE SURVIVAL; SENTINEL LYMPH NODE BIOPSY;

AXILLA; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODES; SENTINEL LYMPH NODE BIOPSY; TREATMENT OUTCOME;

EID: 84855903489     PISSN: 15272729     EISSN: 15346277     Source Type: Journal    
DOI: 10.1007/s11864-011-0170-4     Document Type: Article

References (117)

1. Kuster E. Zur Behandlung des Brustkrebses Verhandlungen der Deutschen Gesellschaft fur Chirurgie. 1883;12:288.
2. Sprengel O. Mittheilungen fiber die in den Jahren 1874 bis 1878 aur der Volkmann'schen Klinik operativ behandelten 131 Falle von Brust-Carcinom. Archir F Klin Chir. 1882;27:805.
3. Banks WM. On free removal of mammary cancer with extirpation of the axillary glands as a necessary accompaniment. Br Med J. 1882;2:1138.
4. Halsted WS. The results of operations for the cure of cancer of the breast performed at the Johns Hopkins Hospital from June 1889 to January 1894. Arch Surg. 1894;20:497.
5. Halsted WS. A clinical and histological study of certain adenocarcinomata of the breast: And a brief consideration of the supraclavicular operation and of the results of operation for cancer of the breast from 1889 to 1898 at the Johns Hopkins Hospital. Ann Surg. 1898;28:557-76.
6. Urban JA. Radical excision of the chest wall for mammary cancer. Cancer. 1951;4(6):1263-85.
7. Urban JA, Baker HW. Radical mastectomy in continuity with en bloc resection of internal mammary lymph-node chain: New procedure for primary operable cancer of breast. Cancer. 1952;5:992-1008.
8. Handley RS, Patey DH, Hand BH. Excision of the internal mammary chain in radical mastectomy. Results in 57 cases. Lancet. 1956;267(6921):457-61.
9. Meier P, Ferguson DJ, Karrison T. A controlled trial of extended radicalmastectomy. Cancer. 1985;55:880-91.
10. Lacour J, Bucalossi P, Caceres E, et al. Radical mastectomy versus radical mastectomy plus internal mammary dissection. Five-year results of an international cooperative study. Cancer. 1976;37:206-14.
11. Veronesi U, Valagussa P. Inefficacy of internal mammary nodes dissection in breast cancer surgery. Cancer. 1981;47:170-5. (Pubitemid 11167377)
12. Patey DH, Dyson WH. The prognosis of carcinoma of the breast in relation to the type of operation performed. Br J Canc. 1948;2:7.
13. Madden JL. Modified radical mastectomy. Surg Gynecol Obstet. 1965;121:1221.
14. Madden JL, Kandalaft S, Bourque R-A. Modified radical mastectomy. Ann Surg. 1972;175:624.
15. Auchincloss H. Significance of location and number of axillary metastases in carcinoma of the breast: A justification for a conservative operation. Ann Surg. 1963;158:37.
16. Nemoto T. Ann Surg. 1975;182(6):722-3.
17. Hultborn A, Hulten L, Roos B, et al. Topography of lymph drainage from mammary gland and hand to axillary lymph nodes. Acta Radiol Ther Phys Biol. 1971;10:65.
18. Hultborn A, Hulten B, Roos B, et al. Effectiveness of axillary lymph node dissection in modified radical mastectomy with preservation of pectoral muscles. Ann Surg. 1974;179:269.
19. Turner L, Swindell R, Bell WGT. Radical versus modified radical mastectomy for breast cancer. Ann R Coll Surg Engl. 1981;63:239-43. (Pubitemid 11125699)
20. Orr RK. The impact of prophylactic axillary node dissection on breast cancer survival-a Bayesian meta-analysis. Ann Surg Oncol. 1999;6:109-16. (Pubitemid 29077496)
21. Fisher B, Redmond C, Fisher ER, et al. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med. 1985;312:674-81. (Pubitemid 15134703)
22. Fisher B, Jeong JH, Anderson S, et al. 25 year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med. 2002;347(8):567-75.
23. Fisher B, Bauer M, Margolese R, et al. Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med. 1985;312:665-73. (Pubitemid 15134702)
24. Fisher B, Redmond C, Poisson R, et al. Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med. 1989;320:822-8. (Pubitemid 19094701)
25. Erratum, N Engl J Med; 330:1467, 1994.
26. Fisher B, Anderson S, Bryant J, et al. 20-year followup of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347(16):1233-41. (Pubitemid 35176242)
27. Veronesi U, Saccozzi R, Del Vecchio M, et al. Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast. N Engl J Med. 1981;305:6-11. (Pubitemid 11071189)
28. Veronesi U, Cascinelli N, Mariani L, et al. 20-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347:1227-32. (Pubitemid 35176241)
29. Harris JR, Hellman S, Kinne DW. Special report: Limited surgery and radiotherapy for early breast cancer. N Engl J Med. 1985;313:1365-8.
30. Fisher B, Wolmark N, Bauer M, et al. The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast. Surg Gynecol Obstet. 1981;152:765-72. (Pubitemid 11072899)
31. Veronesi U, Luini A, Galimberti V, et al. Extent of metastatic axillary involvement in 1446 cases of breast cancer. Eur J Surg Oncol. 1990;16:127-33. (Pubitemid 20150293)
32. Axelsson CK, Mouridsen HT, Zedeler K. Axillary dissection of level I and II lymph nodes is important in breast cancer classification. The Danish Breast Cancer Cooperative Group (DBCG). Eur J Canc. 1992;28A:1415-8.
33. Mathiesen O, Carl J, Bonderup O, et al. Axillary sampling and the risk of erroneous staging of breast cancer. An analysis of 960 consecutive patients. Acta Oncol. 1990;29:721-5. (Pubitemid 20354520)
34. Kiricuta CI, Tausch J. A mathematical model of axillary lymph node involvement based on 1446 complete axillary dissections in patients with breast carcinoma. Cancer. 1992;69:2496-501.
35. Axelsson CK, Rank F, Blichert-Toft M, et al. Impact of axillary dissection on staging and regional control in breast tumors G or = 10 mm-the DBCG experience. The Danish Breast Cancer Cooperative Group (DBCG), Rigshospitalet, Copenhagen, Denmark. Acta Oncol. 2000;39:283-9. (Pubitemid 30643073)
36. Iyer RV,Hanlon A, Fowble B, et al. Accuracy of the extent of axillary nodal positivity related to primary tumor size, number of involved nodes, and number of nodes examined. Int J RadiatOncol Biol Phys. 2000;47:1177-83. (Pubitemid 30421169)
37. Axelsson CK, Mouridsen HT, Düring M, et al. Axillary staging during surgery for breast cancer. Br J Surg. 2007;94(3):304-9. (Pubitemid 46423847)
38. Kaae S, Johansen H. Breast cancer, a comparison of the results of simple mastectomy with postoperative roentgen irradiation by the McWhirter method with those of extended radical mastectomy. Acta Radiol Suppl. 1959;188:155.
39. Johansen H, Kaae S, Schiødt T. Simple mastectomy with postoperative irradiation versus extended radical mastectomy in breast cancer. A 25-year follow-up of a randomized trial. Acta Oncol. 1990;29(6):709-15. (Pubitemid 20354518)
40. Johansen H, Kaae S, Jensen MB, Mouridsen HT. Extended radical mastectomy versus simple mastectomy followed by radiotherapy in primary breast cancer. A 50-year follow-up to the Copenhagen Breast Cancer randomised study. Acta Oncol. 2008;47(4):633-8. (Pubitemid 351878446)
41. Harris J, Osteen R. Patients with early breast cancer benefit from effective axillary treatment. Breast Canc Res Treat. 1985;5:17-21. (Pubitemid 15163213)
42. Martelli G, Boracchi P, De Palo M, et al. A randomized trial comparing axillary dissection to no axillary dissection in older patients with T1N0 breast cancer: Results after 5 years of follow-up. Ann Surg. 2005;242:1-6. (Pubitemid 40917960)
43. Rudenstam CM, Zahrieh D, Forbes JF, et al. Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: First results of International Breast Cancer Study Group Trial 10-93. J Clin Oncol. 2006;24:337-44. (Pubitemid 46630451)
44. Cabanes PA, Salmon RJ, Vilcocq JR, et al. Value of axillary dissection in addition to lumpectomy and radiotherapy in early breast cancer. Lancet. 1992;339:1245-8.
45. Louis-Sylvestre C, Clough K, Asselain B, et al. Axillary treatment in conservative management of operable breast cancer: Dissection or radiotherapy? results of a randomized study with 15 years of follow-up. J Clin Oncol. 2004;22:97-101. (Pubitemid 41095119)
46. Veronesi U, Orecchia R, Zurrida S, et al. Avoiding axillary dissection in breast cancer surgery: A randomized trial to assess the role of axillary radiotherapy. Ann Oncol. 2005;16:383-8. (Pubitemid 40458313)
47. Sanghani M, Balk EM, Cady B. Impact of axillary lymph node dissection on breast cancer outcome in clinically node negative patients: A systematic review and meta-analysis. Cancer. 2009;115(8):1613-20. Comprehensive review with meta-analysis of trials investigating the avoidance of lymphnode dissection.
48. Giuliano AE, Haigh PI, Brennan MB, et al. Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol. 2000;18:2553-9. (Pubitemid 30432521)
49. Schwartz GF, Giuliano AE, Veronesi U. Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19-22, 2001, Philadelphia, Pennsylvania. Cancer. 2002;94:2542-51. (Pubitemid 34478066)
50. Veronesi U, Paganelli G, Viale G, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med. 2003;349:546-53. (Pubitemid 36951366)
51. GipponiM, Bassetti C, CanaveseG, et al. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients. J Surg Oncol. 2004;85(3):102-11. (Pubitemid 38313932)
52. Lyman GH, Giuliano AE, Somerfield MR, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol. 2005;23:7703-20. (Pubitemid 46291835)
53. Bergkvist L, de Boniface J, Jonsson PE, et al. Axillary recurrence rate after negative sentinel node biopsy in breast cancer: Three-year follow-up of the Swedish Multicenter Cohort Study. Ann Surg. 2008;247:150-6.
54. Krag DN, Anderson SJ, Julian TB, et al. Sentinellymph- node resection compared with conventional axillary-lymph-node dissection in clinically nodenegative patients with breast cancer: Overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol. 2010;11:927-33. Large prospective randomized mature Ph3 study providing evidence for sensitivity and specificity of sentinel node sampling, establishing sentinel node biopsy as a reliable alternative to dissection.
55. Veronesi U, Viale G, Paganelli G, et al. Sentinel lymph node biopsy in breast cancer: Ten-year results of a randomized controlled study. Ann Surg. 2010;251(4):595-600. Mature prospective randomized study establishing role of sentinel node biopsy.
56. Mansel RE, Fallowfield L, Kissin M, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: The ALMANAC trial. J Natl Canc Inst. 2006;98:599-609. (Pubitemid 43904843)
57. Tjan-Heijnen VC, Pepels MJ, De Boer G, et al. Impact of omission of completion axillary lymph node dissection (cALND) or axillary radiotherapy (ax RT) in breast cancer patients with micrometastases (pN1mi) or isolated tumor cells (pN0[i?]) in the sentinel lymph node (SN): Results from the MIRROR study. 2009;27:18S. Data from large prospective randomized study evaluating avoidance of specific local axillary therapy despite the finding of micrometastases.
58. Galimberti V. International Breast Cancer Study Group Trial of sentinel node biopsy. J Clin Oncol. 2006;24:210-1. (Pubitemid 46630516)
59. Straver M, Meijnen P, van Tienhoven G, et al. Sentinel node identification rate and nodal involvement in the EORTC 10981-22023 AMAROS trial. Ann Surg Oncol. 2010;17:1854-61. Corroborates sensitivity and feasibility of sentinel node biopsy.
60. Van Zee KJ, Manasseh DM, Bevilacqua JL, et al. A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol. 2003;10(10):1140-51. (Pubitemid 40486808)
61. Naik AM, Fey J, Gemignani M, et al. The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: A follow-up study of 4008 procedures. Ann Surg. 2004;240(3):462-71. (Pubitemid 39121340)
62. Hwang RF, Gonzalez-Angulo AM, Yi M, et al. Low locoregional failure rates in selected breast cancer patients with tumor-positive sentinel lymph nodes who do not undergo completion axillary dissection. Cancer. 2007;110(4):723-30. (Pubitemid 47257646)
63. Bilimoria KY, Bentrem DJ, Hansen NM, et al. Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for nodepositive breast cancer. J Clin Oncol. 2009;27 (18):2946-53. Randomized study with direct comparison of outcomes of completing axillary node dissection or not despite a positive sentinel node.
64. Giuliano AE, McCall L, Beitsch P, et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: The American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg. 2010;252(3):426-33. Specific evaluation of locoregional recurrence in positive sentinel node with or without completion dissection.
65. Giuliano AE, Hunt KK, Ballman KV, et al. Axillary dissection vs. no axillary dissection in women with invasive breast cancer and sentinel node metastasis: A randomized clinical trial. JAMA. 2011;305(6):569-75. Mature data including survival and local recurrence rates for avoidance of completion axillary dissection with a positive sentinel node.
66. McWhirter R. The value of simple mastectomy and radiotherapy in the treatment of cancer of the breast. Br J Radiol. 1948;21:599.
67. McWhirter R. Treatment of cancer of breast by simple mastectomy and roentgenotherapy. Arch Surg. 1949;59:830-42.
68. McWhirter R. Simple mastectomy and radiotherapy in treatment of breast cancer. Br J Radiol. 1955;28:128.
69. Ceilley E, Jagsi R, Goldberg S, et al. Radiotherapy for invasive breast cancer in North America and Europe: Results of a survey. Int J Radiat Oncol Biol Phys. 2005;61(2):365-73. (Pubitemid 40164428)
70. Mansur D, Kong FB, El Naqa I. CT localization of axillary lymph nodes in relation to the humeral head: Significance of arm position for radiation therapy planning. Radiother Oncol. 2005;77:191-3. (Pubitemid 41682386)
71. Bentel GC, Marks LB, Hardenbergh PH, Prosnitz LR. Variability of the depth of supraclavicular and axillary lymph nodes in patients with breast cancer: Is a posterior axillary boost field necessary? Int J Radiat Oncol Biol Phys. 2000;47(3):755-8. (Pubitemid 30317496)
72. Liengsawangwong R, Yu T-K, Sun T-L, et al. Treatment optimization using computed tomographydelineated targets should be used for supraclavicular irradiation for breast cancer. Int J Radiat Oncol Biol Phys. 2007;69(3):711-5. (Pubitemid 47418412)
73. Wang X, Yu T-K, Salehpour M, et al. Breast cancer regional radiation fields for supraclavicular and axillary lymph node treatment: Is a posterior axillary boost field technique optimal? Int J Radiat Oncol Biol Phys. 2009;74(1):86-91.
74. Garg AK, Frija EK, et al. Effects of variable placement of superior tangential/supraclavicular match line on dosimetric coverage of level Iii axilla/axillaryapex in patients treated with breast and supraclavicular radiotherapy. 2009.
75. Li XA, Tai A, Arthur DW, et al. Variability of targetand normal structure delineation for breast cancer radiotherapy: An Rtog multi-institutional and multiobserver study. Int J Radiat Oncol Biol Phys. 2009;73(3):944-51.
76. Chen RC, Lin NU, GolshanM, et al. Internalmammary nodes in breast cancer: Diagnosis and implications for patient management-a systematic review. J Clin Oncol. 2008;26:4981-9.
77. Morimoto T, Monden Y, Takashima S, et al. Five-year results of a randomized clinical trial comparing modified radical mastectomy and extended radical mastectomy for stage II breast cancer. Surg Today. 1994;24:210-4. (Pubitemid 24120220)
78. Recht A, Gray R, Davidson NE, et al. Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: Experience of the Eastern Cooperative Oncology Group. J Clin Oncol. 1999;17:1689-700. (Pubitemid 29269237)
79. Stefanik D, Goldberg R, Byrne P, et al. Local-regional failure in patients treated with adjuvant chemotherapy for breast cancer. J Clin Oncol. 1985;3:660-5. (Pubitemid 15119238)
80. Buzdar AU, McNeese MD, Hortobagyi GN, et al. Is chemotherapy effective in reducing the local failure rate in patients with operable breast cancer? Cancer. 1990;65:394-9.
81. Galper S, Recht A, Silver B, et al. Factors associated with regional nodal failure in patients with early stage breast cancer with 0-3 positive axillary nodes following tangential irradiation alone. Int J Radiat Oncol Biol Phys. 1999;45:1157-66.
82. Paterson R, Russell MH. Breast cancer evaluation of postoperative radiotherapy. J Facul Radiol. 1959; 10:175-80.
83. Høst H, Brennhovd IO, Loeb M. Postoperative radiotherapy in breast cancer-long-term results from the Oslo study. Int J Radiat Oncol Biol Phys. 1986;12 (5):727-32. (Pubitemid 16033469)
84. Rutqvist LE, Pettersson D, Johansson H. Adjuvant radiation therapy versus surgery alone in operable breast cancer: Long-term follow-up of a randomized clinical trial. Radiother Oncol. 1993;26(2):104-10. (Pubitemid 23094675)
85. Haybittle JL, Brinkley D, Houghton J, et al. Postoperative radiotherapy and late mortality: Evidence from the Cancer Research Campaign trial for early breast cancer. BMJ; 298:1611 doi:10.1136/bmj.298.6688.1611 (Published 17 June 1989).
86. Paszata LF, Vallisb KA, Benka VMA, et al. A population- based case-cohort study of the risk of myocardial infarction following radiation therapy for breast cancer. Radiother Oncol. 2007;82:294-300.
87. Whelan TJ, Julian J, Wright J, et al. Does locoregional radiation therapy improve survival in breast cancer? a meta-analysis. J Clin Oncol. 2000;18:1220-9. (Pubitemid 30159839)
88. Freedman GM, Fowble BL, Nicolaou N, et al. Should internal mammary lymph nodes in breast cancer be a target for the radiation oncologist? Int J Radiat Oncol Biol Phys. 2000;46(4):805-14. (Pubitemid 30114391)
89. Fowble B, Hanlon A, Freedman G. Internal mammary node irradiation neither decreases distant metastases nor improves survival in stage I and II breast cancer. Int J Radiat Oncol Biol Phys. 2000;47(4):883-94. (Pubitemid 30345584)
90. Taghian A, Jagsi R, Makris A, et al. Results of a survey regarding irradiation of internal mammary chain in patients with breast cancer: Practice is culture driven rather than evidence based. Int J Radiat Oncol Biol Phys. 2004;60(3):706-14. (Pubitemid 39311749)
91. Patty H. Spruit1, Sabine Siesling2, Marloes regional radiotherapy versus an axillary lymph node dissection after lumpectomy: A safe alternative for an axillary lymph node dissection in a clinically uninvolved axilla in breast cancer. A case control study with 10 years follow up radiation. Oncology. 2007;2:40.
92. Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b trial. N Engl J Med. 1997;337:949-55. (Pubitemid 27425950)
93. Overgaard M, Jensen MB, Overgaard J, et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen DBCG, Danish Breast Cancer Cooperative Group 82c randomized trial. Lancet. 1999;353:1641-8. (Pubitemid 29224519)
94. Nielsen HM, Overgaard M, Grau C, et al. Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: Long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and c Randomized Studies. J Clin Oncol. 2006;24:2268-75. (Pubitemid 46630656)
95. Overgaard M, Nielsen HM, Overgaard J. Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in International consensus reports in a subgroup analysis of the DBCG 82b and c randomized trials. Radiother Oncol. 2007;82:247-53. (Pubitemid 46350797)
96. Kyndi M, Overgaard M, Nielsen HM, et al. High local recurrence risk is not associated with large survival reduction after postmastectomy radiotherapy in high-risk breast cancer: A subgroup analysis of DBCG 82b&c. Radiother Oncol. 2009;90(1):74-9. Mature prospectively randomized data suggesting local recurrence risk is not neccessarily directly related to survival risk specifically high local recurrence risk is not specifically associated with poorer survival.
97. Ragaz J, Jackson SM, Le N, et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med. 1997;337:956-62. (Pubitemid 27425951)
98. Ragaz J, Olivotto IA, Spinelli JJ, et al. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia Randomized Trial. J Natl Canc Inst. 2005;97:116-26. (Pubitemid 40277091)
99. Romestaing P, Belot A, Hennequin C, et al. Ten-years results of a randomized trial of internal mammary chain irradiation after mastectomy: Presented at the 51st Annual Meeting of American Society for Radiation Oncology. Chicago IL, November 1-5, 2009. Long term data suggesting that internal mammrry node radiation does not specifically improve overall survival.
100. Whelan TJ, Olivotto I, Ackerman I, et al. NCIC-CTG MA.20: An intergroup trial of regional nodal irradiation in early breast cancer. ASCO MEETING ABSTRACTS Jun 23: LBA1003, 2011. Prospective randomized study comparing nodal irradiation versus breast irradiation only in the 1-4 node positive group of patients - improved local control, trend to improved survival but not statistically significant, subgroup analysis awaited may identify groups that benefit.
101. Matzinger O, Heimsoth I, Poortmans P, et al. Toxicity at 3 years with and without irradiation of the internal mammary and medial supraclavicular lymph node chain in stage I to III breast cancer (EORTC Trial 22922/10925). Acta Oncol. 2010;49:24-34. Large study evaluating radiation toxicity.
102. Clarke M, Collins R, Darby S, et al. Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials. Lancet. 2005;366(9503):2087-106. (Pubitemid 41797643)
103. Tanis PJ, Nieweg OE, Valdes Olmos RA, et al. Anatomy and physiology of lymphatic drainage of the breast from the perspective of sentinel node biopsy. J Am Coll Surg. 2001;192:399-409. (Pubitemid 32208882)
104. Fowble B, Solin LJ, Schultz DJ, et al. Frequency, sites of relapse, and outcome of regional node failures following conservative surgery and radiation for early breast cancer. Int J Radiat Oncol Biol Phys. 1989;17:703-10. (Pubitemid 19250521)
105. Reddy SG, Kiel KD. Supraclavicular nodal failure in patients with one to three positive axillary lymph nodes treated with breast conserving surgery and breast irradiation, without supraclavicular node radiation. Breast J. 2007;13:12-8. (Pubitemid 46046488)
106. Fisher B, Slack NH, Cavanaugh PJ, et al. Postoperative radiotherapy in the treatment of breast cancer: Results of the NSABP clinical trial. Ann Surg. 1970;172:711-32.
107. Livi L, Scotti V, Saieva C, et al. Outcome after conservative surgery and breast irradiation in 5,717 patients with breast cancer: Implications for supraclavicular nodal irradiation. Int J Radiat Oncol Biol Phys. 2009;76:978-83. Large study informing risk of supraclavicular nodal involvement.
108. Buchholz TA, Woodward WA, Duan Z, et al. Radiation use and long-term survival in breast cancer patients with T1, T2 primary tumors and one to three positive axillary lymph nodes. Int J Radiat Oncol Biol Phys. 2008;71(4):1022-7.
109. Reznik J, Cicchetti MG, Degaspe B, et al. Analysis of axillary coverage during tangential radiation therapy to the breast. Int J Radiat Oncol Biol Phys. 2005;61:163-8. (Pubitemid 40039118)
110. Alonso-Basanta M, Ko J, Babcock M, et al. Coverage of axillary lymph nodes in supine vs. prone breast radiotherapy. Int J Radiat Oncol Biol Phys. 2009;73:745-51. Emphasizes importance of patient positioning in radiation dose delivered to nodes.
111. Reed DR, Lindsley SK, Mann GN, et al. Axillary lymph node dose with tangential breast irradiation. Int J Radiat Oncol Biol Phys. 2005;61(2):358-64. (Pubitemid 40164427)
112. Aristei C, Chionne F, Marsella AR. Evaluation of level I and Ii axillary nodes included in the standard breast tangential fields and calculation of the administered dose: Results of a prospective study. Int J Radiat Oncol Biol Phys. 2001;51(1):69-73. (Pubitemid 32758863)
113. Orecchia R, Huscher A, Leonardi MC. Irradiation with standard tangential breast fields in patients treated with conservative surgery and sentinel node biopsy: Using a three-dimensional tool to evaluate the first level coverage of the axillary nodes. Br J Radiol. 2005;78:51-4. (Pubitemid 40277138)
114. Schlembach PJ, Buchholz TA, Ross MI, et al. Relationship of sentinel and axillary level I-Ii lymph nodes to tangential fields used in breast irradiation. Int J Radiat Oncol Biol Phys. 2005;51(3):671-8.
115. Takeda A, Shigematsu N, Kondo M. The modified tangential irradiation technique for breast cancer: How to cover the entire axillary region. Int J Radiat Oncol Biol Phys. 2000;46(4):815-22. (Pubitemid 30114392)
116. Rabinovitch R, Ballonoff A, Newman F. Evaluation of breast sentinel lymph node coverage by standard radiation therapy fields. Int J Radiat Oncol Biol Phys. 2008;70(5):1468-71. (Pubitemid 351417768)
117. Galper S, Recht A, Silver B, et al. Is radiation alone adequate treatment to the axilla for patients with limited axillary surgery? implications for treatment after a positive sentinel node biopsy. Int J Radiat Oncol Biol Phys. 2000;48:125-32. (Pubitemid 30488222)